Free Trial

Verastem (VSTM) News Today

Verastem logo
$3.92
+0.16 (+4.26%)
(As of 11/1/2024 ET)
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have earned an average rating of "Buy" from the eight ratings firms that are currently covering the stock, Marketbeat.com reports. Eight research analysts have rated the stock with a buy recommendation. The average 12 month price objective a
Verastem, Inc. stock logo
Royal Bank of Canada Reaffirms "Outperform" Rating for Verastem (NASDAQ:VSTM)
Royal Bank of Canada reaffirmed an "outperform" rating and issued a $13.00 target price on shares of Verastem in a research report on Friday.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Given "Overweight" Rating at Cantor Fitzgerald
Cantor Fitzgerald restated an "overweight" rating on shares of Verastem in a research note on Friday.
Verastem, Inc. stock logo
Nantahala Capital Management LLC Purchases Shares of 400,000 Verastem, Inc. (NASDAQ:VSTM)
Nantahala Capital Management LLC acquired a new position in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 400,000 shares of the biopharmaceutical company's stock
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Given Average Recommendation of "Buy" by Analysts
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) has earned a consensus rating of "Buy" from the six research firms that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Receives Average Rating of "Buy" from Analysts
Shares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have earned an average recommendation of "Buy" from the six analysts that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average 1-year price object
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Short Interest Down 18.9% in July
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 1,840,000 shares, a drop of 18.9% from the July 15th total of 2,270,000 shares. Currently, 5.9% of the company's shares are sold short. Based on an average daily trading volume, of 1,020,000 shares, the short-interest ratio is presently 1.8 days.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Given New $15.00 Price Target at Truist Financial
Truist Financial decreased their price objective on shares of Verastem from $18.00 to $15.00 and set a "buy" rating on the stock in a report on Tuesday.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Raised to "Hold" at StockNews.com
StockNews.com upgraded Verastem from a "sell" rating to a "hold" rating in a report on Monday.
Verastem, Inc. stock logo
HC Wainwright Cuts Verastem (NASDAQ:VSTM) Price Target to $7.00
HC Wainwright lowered their price target on Verastem from $17.50 to $7.00 and set a "buy" rating on the stock in a research report on Monday.
Verastem, Inc. stock logo
Royal Bank of Canada Trims Verastem (NASDAQ:VSTM) Target Price to $13.00
Royal Bank of Canada decreased their price target on Verastem from $16.00 to $13.00 and set an "outperform" rating for the company in a research note on Friday.
VSTM Aug 2024 2.000 call
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Lowered to Sell at StockNews.com
StockNews.com downgraded Verastem from a "hold" rating to a "sell" rating in a report on Thursday.
Verastem, Inc. stock logo
Verastem, Inc. Expected to Post Q3 2024 Earnings of ($0.79) Per Share (NASDAQ:VSTM)
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Research analysts at B. Riley upped their Q3 2024 earnings estimates for Verastem in a report issued on Wednesday, July 24th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will post earnings of ($0.79) per share for the quart
Verastem, Inc. stock logo
Short Interest in Verastem, Inc. (NASDAQ:VSTM) Grows By 77.3%
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 2,270,000 shares, a growth of 77.3% from the June 30th total of 1,280,000 shares. Approximately 11.2% of the company's stock are short sold. Based on an average daily volume of 906,700 shares, the days-to-cover ratio is currently 2.5 days.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Price Target Cut to $7.00
B. Riley lowered their price objective on shares of Verastem from $21.00 to $7.00 and set a "buy" rating for the company in a research report on Wednesday.
InflaRx NV (IF0.DU)
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Receives Average Recommendation of "Buy" from Brokerages
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) has earned an average recommendation of "Buy" from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 1 year price target among anal
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Downgraded to Sell at StockNews.com
StockNews.com lowered Verastem from a "hold" rating to a "sell" rating in a report on Friday.
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Short Interest Update
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 1,320,000 shares, a decline of 44.5% from the May 31st total of 2,380,000 shares. Approximately 6.5% of the shares of the company are sold short. Based on an average daily volume of 685,800 shares, the short-interest ratio is presently 1.9 days.
Get Verastem News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

VSTM Media Mentions By Week

VSTM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VSTM
News Sentiment

0.38

0.43

Average
Medical
News Sentiment

VSTM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VSTM Articles
This Week

0

3

VSTM Articles
Average Week

Get Verastem News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VSTM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners